Taiwanese cellphone maker HTC Corp on Thursday said it will strongly defend itself against the patent infringement lawsuits brought by software giant Apple.
Cipla Medpro, which rebuffed rival Adcock Ingram's 2.1 billion rand takeover bid last year, said on Thursday headline earnings per share rose to 36.6 cents compared with 29.1 cents in the previous year.
The tug-of-war over Nexium starts once again. This time, AstraZeneca has filed two separate cases against Sun Pharma to block a Para IV filing on Nexium....
CDMA technology patent holder Qualcomm on Wednesday said it would bid for one of the two slots of the spectrum in the upcoming broadband wireless auction. The San Diego-based company has already participated in such an auction in the US and the UK.
Unimark Remedies Ltd is developing an anti-HIV drug, anti-hypertensive drug and anti-cholesterol drug through biocatalysis for commercial sale purposes at its new dedicated biotechnology
Fun Cinemas launched a five-screen multiplex at AlphaOne in Amritsar on Monday. The multiplex which was inaugrated by deputy chief minister of Punjab Sukhbir Singh Badal will start...
Pharma and healthcare companies are making a strong comeback on the bourses. At least one of these companies have been hitting their 52-week high every day since the last...
Ranbaxy Laboratories on Monday said it has settled a patent litigation with Japan's largest drugmaker Takeda Pharmaceuticals on the $3.4 billion blockbuster drug Actos...
Ranbaxy Laboratories Ltd settled a patent dispute with Takeda Pharmaceutical Co allowing the Indian drugmaker to sell a generic version of Actos, the world’s biggest selling diabetes medicine, in the US.